For millions of people living with osteoarthritis, daily life can involve a frustrating cycle of pain and stiffness. While current treatments like over-the-counter medications or steroid injections can temporarily dull the ache, they do not stop the joint from deteriorating. A Yale study published in the journal Bioactive Materials found that the medication lacosamide acts as a highly effective, dual-purpose treatment that relieves joint pain and reverses cartilage damage in osteoarthritis, especially when a specialized hydrogel delivers the drug directly into the joint.

Understanding osteoarthritis
Oste...

To accelerate and refine decision-making in a fast-paced, global marketplace, enterprises may deploy generative artificial intelligence models to help summarize and interpret the charts that often fill market summaries and financial reports.

But even the latest vision-language models sometimes struggle with this task, since it requires a model to integrate visual, numerical, and linguistic understanding. A company that invests in a state-of-the-art model might still receive inaccurate or incomplete information.

To fill this performance gap, researchers from MIT and the MIT-IBM Computing Research Lab developed a multifaceted resource for AI users that is specifically designed to teach vision-language models (VLMs) how to effectively interpret charts.

They used a novel data gen...

The weather on Earth can get pretty messy sometimes. But in space, it can be wild, and the effects can be far-reaching. Solar flares, giant explosions on the sun, can send out streams of energy that block radio communications and fry satellite electronics. Geomagnetic storms, caused by variations in solar wind, can mess with GPS signals and spark current surges on Earth that overload power grids.

The impact of space weather isn’t limited to temporarily losing electricity or digging out dusty paper maps for directions when satellite navigation systems fail. Every electronic financial transaction in the world, for instance, relies on time stamps sent by satellite systems...

A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.

Combination therapy targets gene-altered tumors
The study, TALAPRO-3 (NCT04821622), evaluated a combination of two drugs—talazoparib and enzalutamide—in patients with metastatic castration-sensitive prostate cancer. This is a form of the disease that has spread beyond the prostate but remains susceptible to standard hormone therapy treatment.

The patients involved also had prostate cancer affected ...